Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/28/1995 | US5470718 Gene code polypeptides |
11/28/1995 | US5470714 One-step free fatty acid determination method |
11/28/1995 | US5470708 Bombardment, genetic engineering |
11/28/1995 | US5470706 Cloning DNA sequences from genomes by preparing vectors |
11/28/1995 | US5470573 Immunogens comprising the non-lytic membrane spanning domain of bacteriophages MS2 or PhiX174 |
11/28/1995 | US5470569 Genetic engineering |
11/28/1995 | US5470560 Method for evaluating immunogenicity |
11/28/1995 | US5470359 Sterile male corn plant |
11/28/1995 | CA2150092A1 Transgenic animals lacking proteolipid protein and method of making such animals |
11/28/1995 | CA1337671C Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms |
11/28/1995 | CA1337642C Neutrophil chemotactic factor, cloned cdna and monoclonal antibodies thereto |
11/28/1995 | CA1337641C Recombinant dna product and method |
11/28/1995 | CA1337640C Recombinant dna product and method |
11/23/1995 | WO1995031729A1 Nucleic acid sequences controlling lung cell-specific gene expression |
11/23/1995 | WO1995031723A1 PHAGE/PHAGEMID DISPLAY LIBRARY COMPRISING RANDOMLY CLEAVED cDNA/GENOMIC DNA OR CLONED GENE |
11/23/1995 | WO1995031574A1 Processes, apparatus and compositions for characterizing nucleotide sequences |
11/23/1995 | WO1995031573A1 High resolution mapping methods and mapping probes |
11/23/1995 | WO1995031572A1 Aminohydrocarbon phosphonate oligonucleotides and uses therefor |
11/23/1995 | WO1995031571A2 Materials and methods for the detection of mycobacteria |
11/23/1995 | WO1995031570A1 MATERIALS AND METHODS FOR THE DETECTION OF $i(MYCOBACTERIUM TUBERCULOSIS) |
11/23/1995 | WO1995031569A1 Detection and differentiation of mycobacterium tuberculosis complex bacteria by direct variant repeat oligotyping |
11/23/1995 | WO1995031566A1 Compositions and methods for targeting gene delivery vehicles |
11/23/1995 | WO1995031565A1 Alphavirus expression vector |
11/23/1995 | WO1995031564A2 Method of introducing pathogen resistance in plants |
11/23/1995 | WO1995031563A1 Complex inducible promoter system derivable from a phage of a lactic acid bacterium (lab), and its use in a lab for production of a desired protein |
11/23/1995 | WO1995031562A1 Process for inhibiting the growth of a culture of lactic acid bacteria, and optionally lysing the bacterial cells, and uses of the resulting lysed culture |
11/23/1995 | WO1995031561A1 Process for the lysis of a culture of lactic acid bacteria by means of a lysin, and uses of the resulting lysed culture |
11/23/1995 | WO1995031560A1 Dna construct for effecting homologous recombination and uses thereof |
11/23/1995 | WO1995031559A2 Methods of inducing gene expression by ionizing radiation |
11/23/1995 | WO1995031558A1 Process for producing hbv surface proteins |
11/23/1995 | WO1995031557A1 Peptide-mediated gene transfer |
11/23/1995 | WO1995031556A1 Glucan-binding proteins, and use thereof |
11/23/1995 | WO1995031555A1 Fusion glycoprotein from hcmv and hsv |
11/23/1995 | WO1995031554A1 Nucleic acid fragments, chimeric genes and methods for increasing the methionine content of the seeds of plants |
11/23/1995 | WO1995031553A1 DNA SEQUENCES CODING FOR ENZYMES CAPABLE OF FACILITATING THE SYNTHESIS OF LINEAR α-1,4 GLUCANS IN PLANTS, FUNGI AND MICROORGANISMS |
11/23/1995 | WO1995031552A2 Human papilloma virus inhibition by a hairpin ribozyme |
11/23/1995 | WO1995031551A1 Novel enzymatic rna molecules |
11/23/1995 | WO1995031550A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins |
11/23/1995 | WO1995031549A1 Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection |
11/23/1995 | WO1995031548A1 Streptococcus pneumoniae capsular polysaccharide genes and flanking regions |
11/23/1995 | WO1995031547A1 Brazzein sweetener |
11/23/1995 | WO1995031546A1 Recombinant human anti-varicella zoster virus antibodies |
11/23/1995 | WO1995031545A2 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein |
11/23/1995 | WO1995031544A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
11/23/1995 | WO1995031543A1 Dna encoding the beta subunit of a mammalian 'maxi-k' potassium channel |
11/23/1995 | WO1995031542A1 Mutant human insulin receptor dna |
11/23/1995 | WO1995031541A2 Methods and compositions for treatment of restenosis and cancer using ribozymes |
11/23/1995 | WO1995031540A1 Trimerising polypeptides, their manufacture and use |
11/23/1995 | WO1995031539A1 Neurotransmitter transporter |
11/23/1995 | WO1995031538A1 Human dna topoisomerase i-alpha |
11/23/1995 | WO1995031537A1 HUMAN OXALYL-CoA DECARBOXYLASE |
11/23/1995 | WO1995031535A1 Ice and ice-like compositions and methods of making same |
11/23/1995 | WO1995031534A1 AN ENZYME WITH β-(1-6)-ENDOGLUCANASE ACTIVITY |
11/23/1995 | WO1995031533A1 AN ENZYME WITH ENDO-1,3(4)-β-GLUCANASE ACTIVITY |
11/23/1995 | WO1995031532A1 Papillomavirus vaccines |
11/23/1995 | WO1995031483A1 Improvements in or relating to peptide delivery |
11/23/1995 | WO1995031482A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
11/23/1995 | WO1995031478A1 CLONING OF NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS |
11/23/1995 | WO1995031477A1 Vectors with multiple hiv-1 tar sequences inhibiting hiv-1 gene expression |
11/23/1995 | WO1995031476A1 Recombinant papilloma virus l1 |
11/23/1995 | WO1995031473A1 Collagen from cell cultures |
11/23/1995 | WO1995031472A1 Chimeric mhc class i antigens for inducing allograft tolerance |
11/23/1995 | WO1995031469A1 Pteridine nucleotide analogs as fluorescent dna probes |
11/23/1995 | WO1995031468A1 Macrophage migration inhibitory factor-3 |
11/23/1995 | WO1995031467A1 Monocyte chemotactic protein-4 |
11/23/1995 | WO1995031466A1 Method of detecting prions in a sample and transgenic animal used for same |
11/23/1995 | WO1995031434A1 Complementary dna and toxins |
11/23/1995 | WO1995031429A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
11/23/1995 | WO1995031216A1 Vaccine against mycobacterial infections |
11/23/1995 | WO1995031215A1 VACCINE FOR $i(MORAXELLA CATARRHALIS) |
11/23/1995 | WO1995031208A1 Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells |
11/23/1995 | WO1995031206A1 P75 tnf receptor promoters |
11/23/1995 | WO1995029257A3 Apolipoprotein e polymorphism and treatment of alzheimer's disease |
11/23/1995 | WO1995029236A3 Lymphocyte activation antigens and antibodies thereto |
11/23/1995 | WO1995028957A3 Methods for inducing t cell tolerance to a tissue or organ graft |
11/23/1995 | WO1995027079A3 Method for reducing background signals in dna replication/detection assays |
11/23/1995 | WO1994013701A3 Delta-like gene expressed in neuroendocrine tumors |
11/23/1995 | DE4417879A1 New DNA sequence encoding amylo:sucrase of Neisseria |
11/23/1995 | DE4417169A1 Increased prodn. of poly:hydroxy:alkanoate in prokaryotic cells |
11/23/1995 | CA2578402A1 Human papilloma virus inhibition by a hairpin ribozyme |
11/23/1995 | CA2490080A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
11/23/1995 | CA2201772A1 Streptococcus pneumoniae capsular polysaccharide genes and flanking regions |
11/23/1995 | CA2190576A1 Chimeric mhc class i antigens for inducing allograft tolerance |
11/23/1995 | CA2190529A1 Fusion glycoprotein from hcmv and hsv |
11/23/1995 | CA2190513A1 Methods and compositions for treatment of restenosis and cancer using ribozymes |
11/23/1995 | CA2190471A1 Processes, apparatus and compositions for characterizing nucleotide sequences |
11/23/1995 | CA2190466A1 Monocyte chemotactic protein-4 |
11/23/1995 | CA2190375A1 Vectors with multiple hiv-1 tar sequences inhibiting hiv-1 gene expression |
11/23/1995 | CA2190353A1 Cloning of non-iga fc binding forms of the group b streptococcal beta antigens |
11/23/1995 | CA2190289A1 Dna construct for effecting homologous recombination and uses thereof |
11/23/1995 | CA2190264A1 Trimerising polypeptides, their manufacture and use |
11/23/1995 | CA2190262A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
11/23/1995 | CA2190161A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein |
11/23/1995 | CA2190160A1 Method of detecting prions in a sample and transgenic animal used for same |
11/23/1995 | CA2190145A1 Complementary dna and toxins |
11/23/1995 | CA2190120A1 Mutant human insulin receptor dna |
11/23/1995 | CA2190102A1 Human papilloma virus inhibition by a hairpin ribozyme |
11/23/1995 | CA2190101A1 Improvements in or relating to peptide delivery |
11/23/1995 | CA2190091A1 Materials and methods for the detection of mycobacterium tuberculosis |
11/23/1995 | CA2190090A1 Materials and methods for the detection of mycobacteria |